Page 2 - Applied Testing News Today

First partnership in the new QIAseq Platform Partnership to increase compatibility of QIAGEN NGS kits with third-party digital data-sharing and analytics companies Bringing together QIAGEN's

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE: QGEN) that will pair QIAseq reagent technology with

Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class CCertification marks milestone in QIAGEN’s transition to full compliance with new EU regulations for IVD performance and safetyQIAGEN will ensure continuous supply of QuantiFERON-TB Gold PlusVENLO, The Netherlands--(...

Certification of QuantiFERON-TB Gold Plus under more stringent EU regulation, classified under Class C Certification marks milestone in QIAGEN's transition to full compliance with new EU regulations

Start of worldwide diagnostic use follows the launch of upgraded EZ2 Connect for research use in 2021, builds on the success of EZ1 Connect platform found in thousands of labs worldwide EZ2

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the fourth quarter and full-year 2022. Press release date time: Tuesday, February 7, shortly after

Start of worldwide diagnostic use follows the launch of upgraded EZ2 Connect for research use in 2021, builds on the success of EZ1 Connect platform found in thousands of labs worldwide EZ2... | January 17, 2023

17.01.2023 - QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the fourth quarter and full-year 2022. Press release date / time: Tuesday, February 7, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 ...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Partnership to leverage the Helix® Laboratory Platform and QIAGENs biopharma relationships, NGS capabilities, and global regulatory expertise Addressing...